Abstract:Objective: To investigate the influence of kidney-tonifying and blood-generating method on platelet (PLT) growth in the treatment of aplastic anemia (AA) and analyze the characteristics of the clinical factors affecting PLT growth. We enrolled patients treated from September 2018 to March 2021 in the China Academy of Traditional Chinese Medicine (TCM) Xiyuan Hospital, China Academy of TCM hospital gate 19 sub-center. We enrolled 128 AA patients, for whom the inclusion criteria were: treatment is given priority to with kidney and heart's-blood method, on the basis of western medicine treatment for kidney fill party avoid Fried instant particles, stay for 3 months for a period of treatment, taking two consecutive period of treatment, changes in the PLT were observed, and the clinical characteristics of AA patients, such as PLT growth and recovery from baseline value, were analyzed. Materials and Methods: A total of 128 AA patients from 19 branches of Xiyuan Hospital, China Academy of Chinese Medical Sciences and Guang'anmen Hospital, China Academy of Chinese Medical Sciences treated from September 2018 to March 2021 were enrolled. The treatment was based on the kidney-tonifying and blood-generating method and lasted for 3 months as a course of treatment. The changes in the number of PLT in patients were observed, and the clinical characteristics of AA affecting PLT growth and recovery from baseline value were analyzed. Results: After 6 months of treatment following the kidney-tonifying and blood-generating method, PLT increased from the baseline values in 75 cases, including 21 cases of AA with normal PLT recovery and 54 cases of AA without normal PLT recovery. There were 53 cases of AA in whom PLT did not increase from the baseline. Analysis of the general data showed that patients with lower Karnofsky Performance Status (KPS) score were more likely to experience PLT growth or even return to normal after therapy ( P < 0.05). The results of routine blood analysis showed that when hemoglobin (HGB) was ≥60 g/L and the reticulocyte (RET) proportion was ≥0.3% before treatment, PLTs were more likely to increase, even returning to normal in some patients ( P < 0.05). Analysis of bone puncture results before treatment showed that when the proliferation of nucleated cells was low or extremely low in bone puncture examination, with the proportion of granulocytes <40%, and the proportion of erythroid cells <20%, the treatment method was more effective at increasing PLT count ( P < 0.05). Analysis of the chromosome karyotype results before treatment showed that when the chromosome karyotype was normal, PLTs were more likely to increase or even return to normal after treatment ( P < 0.05). Analysis of T-lymphocyte subsets before treatment showed that when CD3+ human leukocyte antigen (HLA)-DR+ proportion was ≥30%, PLTs were more likely to increase or even return to normal ( P < 0.05). Conclusions: AA patients with a low KPS score, higher HGB ≥60 g/L, RET proportion ≥0.3%, low or extremely low proliferation of nucleated cells, granulocytes proportion <40%, erythroid proportion <20%, normal chromosome karyotype, CD3+HLA-DR+ ≥30%, should be treated with a kidney-tonifying and blood-generating method. Such patients are more likely to show PLT growth and the values may even return to normal.

Analysis of count and grade of reticulocyte before and after blood donation from 36 blood donors

[Short-Term Effects of Hemogram in Healthy Donors after Peripheral Blood Stem Cell Collection].

A Multivariate Analysis of the Risk of Iron Deficiency in Plateletpheresis Donors Based on Logistic Regression

[Effect of RBC Transfusion on T Lymphocyte Subsets of Patients with Hematologic Malignancies].

Clinical Observation on Hemogram Variation of Allogeneic Donors from Chinese Population for Peripheral Hematopoietic Stem Cell Collection.

Analysis of erythrocyte and iron study data among plateletpheresis donors in Hangzhou, China

Exploration of the Healthy Donor Effect Among 0.6 Million Blood Donors in China: Longitudinal Study

Influence of Recombinant Human Granulocyte Colony Stimulating Factor (Rhg-Csf) on CD34+ Hematopoietic Stem Cells and Regulatory T Cells in Healthy Donors

Clinical factors affecting platelet growth in the treatment of aplastic anemia by tonifying kidney and generating blood

Impact of Regular Whole-Blood Donation on Body Iron Stores

Investigation on related factors of CD 34+ cells in peripheral blood mobilization effect by G-SCF stimulation

Effects of peripheral blood CD34 + cells count on the collection timing and results of peripheral blood stem cells

[Effect of Bone Marrow Graft Collection on Composition of Peripheral Blood Stem Cell Grafts from Healthy Donors after Recombinant Human Granulocyte Colony-Stimulating Factor Application in Vivo for Mobilization].

Analysis of Erythrocyte Parameters in Multiple and Long-Term Blood Donors from Northern Pomerania (Poland)

The application of erythrocyte and reticulocyte related indices in anemia and bone marrow transplantation

[Retrospective Analysis of Blood Test Results of Volunteer Blood Donors]

Analysis of the demographic and blood donation behavior of repeat blood donors and first-time donors——based on the data of blood donors in Zhejiang province from 2006 to 2015

Investigating the influence of iron parameters in regulating platelet recovery in Apheresis Platelet Donors

Analysis of Efficacy of Apheresis Platelets Transfusion on Patients with Haematological Diseases

Evaluation of strategy to recruit low-risk regular apheresis donors in Zhejiang Blood Center

Clinical Observation of Factors in the Efficacy of Blood Component Transfusion in Patients Following Hematopoietic Stem Cell Transplantation